Pharmacokinetics and Safety of Levofloxacin for Treatment of Rifampicin-Resistant Tuberculosis During Pregnancy and the Postpartum Period: Results from IMPAACT P1026s.
Saved in:
| Title: | Pharmacokinetics and Safety of Levofloxacin for Treatment of Rifampicin-Resistant Tuberculosis During Pregnancy and the Postpartum Period: Results from IMPAACT P1026s. |
|---|---|
| Authors: | Hughes JA; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Francie van Zijl Drive, Tygerberg, Cape Town, 7505, South Africa. jhughes@sun.ac.za., Pinilla M; Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, MA, USA., Brooks KM; Department of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado Anschutz Medical Campus, Aurora, CO, USA., Eke AC; Department of Gynecology and Obstetrics, Johns Hopkins University School of Medicine, Baltimore, MD, USA., Stek A; Department of Obstetrics and Gynecology, University of Southern California School of Medicine, Los Angeles, CA, USA., Best BM; Division of Clinical Pharmacy and Department of Pediatrics, University of California San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences and School of Medicine-Rady Children's Hospital San Diego, San Diego, CA, USA., Mirochnick M; Division of Neonatology, Department of Pediatrics, Boston University Chobanian and Avedisian School of Medicine, Boston, MA, USA., Browning R; National Institutes of Health, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA., Wiesner L; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa., George K; FHI 360, Durham, NC, USA., Knowles K; Frontier Science Foundation, Amherst, NY, USA., De Koker P; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Francie van Zijl Drive, Tygerberg, Cape Town, 7505, South Africa., Ngocho JS; Department of Epidemiology and Applied Biostatistics, Kilimanjaro Christian Medical University College, Moshi, Tanzania., Fairlie L; Wits RHI, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa., Chakhtoura N; Maternal and Pediatric Infectious Disease Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Bethesda, MD, USA., Hesseling AC; Desmond Tutu TB Centre, Department of Paediatrics and Child Health, Faculty of Medicine and Health Sciences, Stellenbosch University, Francie van Zijl Drive, Tygerberg, Cape Town, 7505, South Africa., Decloedt E; Division of Clinical Pharmacology, Department of Medicine, Tygerberg Hospital, Stellenbosch University, Cape Town, South Africa., Shapiro DE; Center for Biostatistics in AIDS Research, Harvard T. H. Chan School of Public Health, Boston, MA, USA., van Schalkwyk M; Division of Adult Infectious Diseases, Department of Medicine, Family Centre for Research with Ubuntu, Stellenbosch University and Tygerberg Hospital, Francie van Zijl Drive, Tygerberg, Cape Town, 7505, South Africa. marije@sun.ac.za. |
| Corporate Authors: | IMPAACT P1026s Protocol Team |
| Source: | Clinical pharmacokinetics [Clin Pharmacokinet] 2025 Apr; Vol. 64 (4), pp. 619-630. Date of Electronic Publication: 2025 Mar 28. |
| Publication Type: | Journal Article; Observational Study |
| Journal Info: | Publisher: Adis, part of Springer Science+Business Media Country of Publication: Switzerland NLM ID: 7606849 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1926 (Electronic) Linking ISSN: 03125963 NLM ISO Abbreviation: Clin Pharmacokinet Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1179-1926 |
|---|---|
| DOI: | 10.1007/s40262-025-01498-0 |
